GO_REF:0000002

Gene Ontology annotation through association of InterPro records with GO terms

InterPro2GO mapping infers GO terms (protoheme IX farnesyltransferase activity, heme A / heme O biosynthetic process, mitochondrial inner membrane) for COX10 from its conserved UbiA prenyltransferase / Cox10 domain signature.

GO_REF:0000033

Annotation inferences using phylogenetic trees

PAINT/PANTHER phylogenetic annotation transfers experimentally validated COX10 / heme O synthase functions across orthologs, supporting human COX10 annotation to protoheme IX farnesyltransferase activity and heme A biosynthetic process.

GO_REF:0000052

Gene Ontology annotation based on curation of immunofluorescence data

Curation of Human Protein Atlas immunofluorescence images supports COX10 mitochondrial localization at IDA evidence level.

GO_REF:0000107

Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara

Ensembl Compara orthology-based transfer propagates experimentally verified heme A biosynthesis / mitochondrial inner membrane annotations from COX10 orthologs to human COX10.

GO_REF:0000117

Electronic Gene Ontology annotations created by ARBA machine learning models

ARBA machine-learning rules predict GO terms (protoheme IX farnesyltransferase activity, heme A biosynthetic process, mitochondrial inner membrane) for COX10 from sequence and family features.

GO_REF:0000120

Combined Automated Annotation using Multiple IEA Methods

A combined automated pipeline integrating multiple IEA methods produces high-confidence IEA annotations of COX10 to the mitochondrial inner membrane and protoheme IX farnesyltransferase activity.

PMID:12928484

Mutations in COX10 result in a defect in mitochondrial heme A biosynthesis and account for multiple, early-onset clinical phenotypes associated with isolated COX deficiency.

Biallelic COX10 missense mutations cause isolated cytochrome c oxidase deficiency with a broad phenotypic spectrum (Leigh syndrome, hypertrophic cardiomyopathy, sensorineural deafness, anemia, tubulopathy / leukodystrophy), establishing COX10 as a major COX assembly disease gene.

"This study shows that mutations in this gene can cause nearly the full range of clinical phenotypes associated with early onset isolated COX deficiency."
COX10 catalyses the first step of the mitochondrial heme A biosynthetic pathway, converting protoheme (heme B) to heme O by farnesylation of the C2 vinyl group, and patient heme A content is reduced in proportion to residual COX enzyme activity.

"COX10 functions in the first step of the mitochondrial heme A biosynthetic pathway, catalyzing the conversion of protoheme (heme B) to heme O via the farnesylation of a vinyl group at position C2."
Retroviral re-expression of COX10 functionally complements patient fibroblast COX deficiency and reduced heme A content is rescued, providing direct cellular evidence that COX10 catalytic loss-of-function is the disease mechanism.

"expression of COX10 from a retroviral vector complements the COX deficiency in a patient with anemia and Leigh Syndrome, and in a patient with anemia, sensorineural deafness and fatal infantile hypertrophic cardiomyopathy."

PMID:14607829

Cytochrome c oxidase subassemblies in fibroblast cultures from patients carrying mutations in COX10, SCO1, or SURF1.

COX10-deficient fibroblasts accumulate early MTCO1-only Complex IV subassemblies and fail to form the MTCO1·COX4·COX5A intermediate, establishing that heme A incorporation into MTCO1 must occur before MTCO1 associates with COX4 and COX5A.

"The MTCO1.COX4.COX5A subassembly was not detected in COX10-deficient cells, which suggests that heme A incorporation into MTCO1 occurs prior to association of MTCO1 with COX4 and COX5A."
Comparison of COX10, SCO1 and SURF1 mutant fibroblasts maps three distinct stalling points of human CIV assembly, placing COX10-dependent MTCO1 hemylation upstream of Cu(A) installation (SCO1) and of MTCO2 incorporation (SURF1).

"SCO1-deficient cells contained accumulated levels of the MTCO1.COX4.COX5A subassembly, suggesting that MTCO2 associates with the MTCO1.COX4.COX5A subassembly after the Cu(A) center of MTCO2 is formed."

PMID:34800366

Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context.

Quantitative mass-spectrometry-based mitochondrial proteomics confirms COX10 as a high-confidence mitochondrial protein and provides HTP evidence for its mitochondrion / inner membrane localization.

"Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context"

PMID:8078902

Isolation of a human cDNA for heme A:farnesyltransferase by functional complementation of a yeast cox10 mutant.

Cloned the human COX10 cDNA encoding a 443-aa heme A:farnesyltransferase by functional complementation of a yeast cox10-null mutant, providing the original molecular identification of human COX10.

"We have cloned the human homolog of the Saccharomyces cerevisiae COX10 gene by functional complementation of a yeast cox10 null mutant."
Demonstrates strong sequence and functional homology between human COX10 and the yeast and bacterial farnesyltransferases (heme O synthases), justifying transfer of yeast/bacterial Cox10 function to the human ortholog.

"The 2.8-kb cDNA encoding the human heme A:farnesyltransferase codes for a 443-aa protein with high homology to the yeast and bacterial farnesylases."

Reactome:R-HSA-189451

Heme biosynthesis

Reactome curates COX10 as a participant in the broad heme biosynthesis pathway; the more specific heme O / heme A biosynthetic-process annotations and COX10-specific Reactome reaction better capture its enzymatic role.

Reactome:R-HSA-2995330

COX10 transforms heme to heme O

Reactome's reaction "COX10 transforms heme to heme O" describes the COX10-catalysed first step of heme A biosynthesis at the mitochondrial inner membrane, supporting the protoheme IX farnesyltransferase activity (GO:0008495) annotation at TAS evidence level.

file:human/COX10/COX10-deep-research-falcon.md

Falcon deep research report on COX10

COX10 catalyzes the first committed step of heme A biosynthesis, transferring a farnesyl group from farnesyl diphosphate to the C2 vinyl group (pyrrole ring A) of heme b/protoheme IX to form heme O.

"**COX10 catalyzes conversion of heme b (protoheme IX) to heme o** by transferring a **farnesyl moiety from farnesyl diphosphate** to the **vinyl group at C2 (pyrrole ring A) of heme b**, producing heme o (a prenylated heme intermediate)."
The proposed catalytic mechanism involves Mg2+-assisted ionization of farnesyl diphosphate, forming a farnesyl cation that is attacked by the heme vinyl group, with pyrophosphate release.

"the reaction is proposed to involve **Mg2+-assisted ionization of farnesyl diphosphate** to form a stabilized **farnesyl cation**, followed by **attack of the heme vinyl** to form the C–C bond; **pyrophosphate release** is implied by the diphosphate ionization step and the described donor chemistry."
Heme A biosynthesis is a two-step mitochondrial pathway: COX10 converts heme b to heme o, then COX15 converts heme o to heme a.

"Heme A is produced by a two-step pathway in mitochondria: 1) **COX10 (heme o synthase): heme b → heme o** (prenylation), and 2) **COX15 (heme a synthase): heme o → heme a**"
Heme A is used exclusively by cytochrome c oxidase (Complex IV) and is required for catalytic function as well as proper maturation/stability of the catalytic core subunit COX1.

"Heme A is uniquely used by **cytochrome c oxidase (Complex IV)** and is required not only for catalysis but also for proper maturation/stability of the catalytic core subunit **COX1**."
COX10 is an integral mitochondrial inner membrane protein.

"COX10 is an **integral mitochondrial inner membrane protein**."
COX10 is a ~46 kDa polytopic inner membrane enzyme with a predicted 8-9 transmembrane helices and a matrix-facing catalytic site; it assembles into homo-oligomeric complexes of ~300 kDa.

"- **~46 kDa**, evolutionarily conserved, - predicted **8–9 transmembrane helices**, with the **catalytic site facing the matrix**, and - assembling into **homo-oligomeric complexes (~300 kDa)**."
Human COX10 is associated with COX15 and copper/metallochaperone factors (COX11, SCO1, SCO2, COA3, COX16, PET191, COX19) and was detected in the SURF1 interactome, integrating heme A biosynthesis with Complex IV assembly.

"human COX10 is trapped together with COX15 and multiple copper/metallochaperone factors (e.g., COX11, SCO1/2, COA3, COX16, PET191, COX19), linking heme A biosynthesis with copper delivery modules and early assembly intermediates. COX10 silencing impacted levels of PET191/COX19 and impaired formation of early metallochaperone complexes, supporting a systems-level role in complex IV biogenesis beyond a standalone enzymatic step."
COX10 oligomerization depends on newly synthesized COX1 and early COX1 assembly intermediates, coupling heme A production to the assembly state of Complex IV.

"mitochondrial heme reviews describe COX10 oligomerization as depending on newly synthesized **COX1** and early COX1 assembly intermediates, consistent with heme A production being tuned to the assembly state of complex IV."
Loss-of-function COX10 alleles disrupt heme A supply to cytochrome c oxidase, causing Complex IV deficiency and Leigh(-like) syndromes.

"Loss-of-function COX10 alleles disrupt heme A supply to cytochrome c oxidase, leading to **complex IV deficiency**; COX10 mutations are repeatedly discussed as causes of severe mitochondrial disease presentations including **Leigh(-like) syndromes** and other complex IV deficiency phenotypes."
COX10 belongs to the UbiA intramembrane aromatic prenyltransferase family. Orthology between human COX10 and yeast Cox10 was established by functional complementation.

"Human **COX10** (UniProt **Q12887**) corresponds to **protoheme IX farnesyltransferase, mitochondrial**, also called **heme O synthase**; it belongs to the **UbiA intramembrane aromatic prenyltransferase family** that catalyzes membrane-embedded prenyl transfer reactions. Orthology between human COX10 and yeast Cox10 was established by functional complementation."
A 2024 yeast complementation assay of 25 human COX10 variants found 11/25 supported ~50% or more of reference cytochrome c oxidase activity; ClinVar had 102 COX10 variants as of Jun 2024, with ~75% classified as variants of uncertain significance.

"**ClinVar listed 102 COX10 variants** as of **17 Jun 2024**, with **nearly three-quarters** categorized as **variants of uncertain significance (VUS)**. (voges2024phenotypicassessmentof pages 1-2) - The authors tested **25 human COX10 variants**; **11/25** supported **~50% or more** of reference cytochrome c oxidase activity and also grew robustly on nonfermentable medium."
A small assembly factor COA2 stabilizes the COX10 complex; COX10 and COX15 function together for heme A synthesis.

"COX10 and COX15 are described as interacting/working together for heme A synthesis, and a small assembly factor **COA2** is described as stabilizing the COX10 complex."